Robotic perturbation proteomics and AI agents enable scalable drug mechanism discovery
Yuming Jiang, Cameron S. Movassaghi, Jesús Muñoz‐Estrada, Niveda Sundararaman, Amanda Momenzadeh, Jesse G. Meyer
This paper develops a platform combining robotic proteomics and AI to enable scalable drug mechanism discovery through high-throughput data analysis and hypothesis generation.
bioRxiv · May 7, 2026 · PreprintSystems Biology